Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Cancer Epidemiol Biomarkers Prev

Retrieve available abstracts of 142 articles:
HTML format



Single Articles


    October 2024
  1. SARMIENTO DD, Tumas N, Pereyra SA, Scruzzi GF, et al
    Social determinants of breast cancer screening: a multilevel analysis of proximal and distal factors related to the practice of mammography.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 3. doi: 10.1158/1055-9965.EPI-24-1001
    PubMed     Abstract available


  2. MARCUS POST L, Pathak DR, Hamilton AS, Hirko KA, et al
    Adiposity throughout Adulthood and Risk of Young Onset Breast Cancer Tumor Subtypes in the Young Women's Health History Study.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 2. doi: 10.1158/1055-9965.EPI-24-1067
    PubMed     Abstract available


  3. WOOF VG, Howell A, Fox L, McWilliams L, et al
    Are women's breast cancer risk appraisals in line with updated clinical risk estimates communicated? Results from a UK Family History Risk and Prevention Clinic.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 2. doi: 10.1158/1055-9965.EPI-24-0581
    PubMed     Abstract available


  4. ARANDA-GUTIERREZ A, Soto-Perez-de-Celis E
    The Disconnect between Clinical Guidelines and Reality: The Case of Trastuzumab.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1259-1260.
    PubMed     Abstract available


  5. ABE JV, Legaspi J, Guillermo C, Bogumil D, et al
    Breast, Colorectal, and Prostate Cancer Incidence among Filipino Americans by Generational Status in the Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1311-1317.
    PubMed     Abstract available


    September 2024
  6. WOJCIK KM, Wilson OWA, Shiels MS, Sheppard VL, et al
    Racial, Ethnic, and Socioeconomic Disparities in Meeting Physical Activity Guidelines among Female Breast Cancer Survivors in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  7. KALIA SS, Boddicker NJ, Yadav S, Huang H, et al
    Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


    August 2024
  8. BRANTLEY KD, Ziegler RG, Craft NE, Hankinson SE, et al
    Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  9. PARK GE, Kim SH, Han K
    A Large Cohort Study of Height and Mammographic Density in Relation to Breast Cancer Risk among Korean Women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  10. SINGH RK, Getz KR, Kyeyune JK, Jeon MS, et al
    Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1126-1128.
    PubMed     Abstract available


    July 2024
  11. BHIMANI J, O'Connell K, Persaud S, Blinder V, et al
    Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  12. ANG BH, Teo SH, Ho WK
    Systematic review and meta-analysis of lifestyle and reproductive factors associated with risk of breast cancer in Asian women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  13. NORRIS RP, Dew R, Greystoke A, Cresti N, et al
    Socio-demographic disparities in HER2+ breast cancer trastuzumab receipt: An English population-based study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  14. ABUBAKAR M, Ahearn TU, Duggan MA, Lawrence S, et al
    Contribution of pre-diagnostic host factors to shaping the stromal microenvironment of breast cancer among sub-Saharan African women.
    Cancer Epidemiol Biomarkers Prev. 2024 Jul 3. doi: 10.1158/1055-9965.EPI-24-0390
    PubMed     Abstract available


  15. OH H, Yaghjyan L, Heng YJ, Rosner B, et al
    Associations of Early-Life and Adult Anthropometric Measures with the Expression of Stem Cell Markers CD44, CD24, and ALDH1A1 in Women with Benign Breast Biopsies.
    Cancer Epidemiol Biomarkers Prev. 2024;33:933-943.
    PubMed     Abstract available


    June 2024
  16. LOHANI KR, Nibbe AM, Vierkant RA, Pacheco-Spann LM, et al
    Understanding benign breast disease and subsequent breast cancer in Hispanic white females; a step closer to evidence-based management.
    Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0204
    PubMed     Abstract available


  17. YAGHJYAN L, Wang Z, Warner ET, Rosner B, et al
    Reproductive Factors Related to Childbearing and a Novel Automated Mammographic Measure, V.
    Cancer Epidemiol Biomarkers Prev. 2024;33:804-811.
    PubMed     Abstract available


    May 2024
  18. YE Z, Nguyen TL, Dite GS, Maclnnis RJ, et al
    Mammographic texture versus conventional Cumulus measure of density in breast cancer risk prediction: a literature review.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  19. FREEMAN JQ, Huo D
    Addressing Social Determinants in the Era of Precision Medicine in Breast Cancer: Is It Sufficient to Reduce Disparities?
    Cancer Epidemiol Biomarkers Prev. 2024;33:635-637.
    PubMed     Abstract available


  20. JATOI I
    Breast Cancer Screening: Can We Justify Deescalation?
    Cancer Epidemiol Biomarkers Prev. 2024;33:638-640.
    PubMed     Abstract available


  21. PARK JE, Smith MA, Van Alsten SC, Walens A, et al
    Diffsig: Associating Risk Factors with Mutational Signatures.
    Cancer Epidemiol Biomarkers Prev. 2024;33:721-730.
    PubMed     Abstract available


  22. VAN ALSTEN SC, Dunn MR, Hamilton AM, Ivory JM, et al
    Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status.
    Cancer Epidemiol Biomarkers Prev. 2024;33:654-661.
    PubMed     Abstract available


    April 2024
  23. PARADA H, Wu T, Hoh E, Rock CL, et al
    Red Blood Cell Polyunsaturated Fatty Acids and Mortality Following Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  24. COLLISTER JA, Liu X, Littlejohns TJ, Cuzick J, et al
    Assessing the value of incorporating a polygenic risk score with non-genetic factors for predicting breast cancer diagnosis in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  25. MOSS JL, Geyer NR, Lengerich EJ
    Patterns of Cancer-Related Healthcare Access across Pennsylvania: Analysis of Novel Census Tract-Level Indicators of Persistent Poverty.
    Cancer Epidemiol Biomarkers Prev. 2024;33:616-623.
    PubMed     Abstract available


  26. BARBER LE, McCullough LE, Johnson DA
    Eyes Wide Open: Sleep as a Potential Contributor to Racial and Ethnic Disparities in Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024;33:471-479.
    PubMed     Abstract available


  27. HAN E, Van Horn L, Snetselaar L, Shepherd JA, et al
    The Associations between Intakes of One-Carbon Metabolism-Related Vitamins and Breast Density among Young Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:567-575.
    PubMed     Abstract available


    March 2024
  28. SIEGEL SD, Zhang Y, Lynch SM, Rowland J, et al
    A Novel Approach for Conducting a Catchment Area Analysis of Breast Cancer by Age and Stage for a Community Cancer Center.
    Cancer Epidemiol Biomarkers Prev. 2024 Mar 7. doi: 10.1158/1055-9965.EPI-23-1125
    PubMed     Abstract available


  29. LEE M, Kotake R, Yamauchi H
    Physical Activity and Mammographic Density in Japanese Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:365-370.
    PubMed     Abstract available


    February 2024
  30. FARBER R, Houssami N, McGeechan K, Barratt A, et al
    Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  31. ANDERSEN HH, Bojesen SE, Johansen JS, Ejlertsen B, et al
    Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  32. UONG SP, Torres JM, Alexeeff SE, Morey BN, et al
    Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among Women Diagnosed with Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


  33. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    PubMed     Abstract available


  34. PEILA R, Rohan TE
    Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2024;33:333-336.
    PubMed     Abstract available


    January 2024
  35. ZELDIN J, Sandler DP, Ogunsina K, O'Brien KM, et al
    Association of fibroids, endometriosis, and gynecologic surgeries with breast cancer incidence and hormone receptor subtypes.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available


    December 2023
  36. AIELLO BOWLES EJ, Kroenke CH, Chubak J, Bhimani J, et al
    Evaluation of algorithms using automated health plan data to identify breast cancer recurrences.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  37. GARDUNO-ALANIS A, Angeles-Llerenas A, Sanchez-Zamorano LM, Flores-Luna L, et al
    Sugar-sweetened beverage consumption and breast cancer in pre- and post-menopausal women.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  38. YE Z, Dite GS, Nguyen TL, Maclnnis RJ, et al
    Genetic and environmental causes of variation in an automated breast cancer risk factor based on mammographic textures.
    Cancer Epidemiol Biomarkers Prev. 2023 Dec 7. doi: 10.1158/1055-9965.EPI-23-1012
    PubMed     Abstract available


  39. TRAN TXM, Kim S, Park B
    Mammographic Breast Density and Risk of Ovarian Cancer in Korean Women.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1690-1698.
    PubMed     Abstract available


  40. HODGE JM, Patel AV, Islami F, Jemal A, et al
    Educational Attainment and Cancer Incidence in a Large Nationwide Prospective Cohort.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1747-1755.
    PubMed     Abstract available


    November 2023
  41. LORONA NC, Othus M, Malone KE, Linden HM, et al
    Alcohol, smoking, and risks of breast cancer recurrence and mortality among women with luminal, triple-negative, and HER2-overexpressing breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  42. LORD SJ, Daniels B, O'Connell DL, Kiely BE, et al
    Decline in the incidence of distant recurrence of breast cancer: A population-based health record linkage study, Australia 2001-2016.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  43. GOLDFINGER E, Stoler J, Goel N
    A multi-scale space-time epidemiological analysis of neighborhood correlates of triple negative breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  44. PETERS BA, Kelly L, Wang T, Loudig O, et al
    The breast microbiome in breast cancer risk and progression: a narrative review.
    Cancer Epidemiol Biomarkers Prev. 2023 Nov 9. doi: 10.1158/1055-9965.EPI-23-0965
    PubMed     Abstract available


  45. TEHRANIFAR P, Bertrand KA
    Enhancing Mammography and Empowering Solutions for Breast Cancer Disparities.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1479-1481.
    PubMed     Abstract available


  46. CHATTERJEE N, Dun Y
    From Hazard Rate to Age-at-Onset Distribution: Mind the Gap.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1477-1478.
    PubMed     Abstract available


  47. NYANTE SJ, Abraham L, Aiello Bowles EJ, Lee CI, et al
    Racial and Ethnic Variation in Diagnostic Mammography Performance among Women Reporting a Breast Lump.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1542-1551.
    PubMed     Abstract available


  48. HUBBARD RA, Pujol TA, Alhajjar E, Edoh K, et al
    Sources of Disparities in Surveillance Mammography Performance and Risk-Guided Recommendations for Supplemental Breast Imaging: A Simulation Study.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1531-1541.
    PubMed     Abstract available


  49. KERLIKOWSKE K, Bissell MCS, Sprague BL, Tice JA, et al
    Impact of BMI on Prevalence of Dense Breasts by Race and Ethnicity.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1524-1530.
    PubMed     Abstract available


    October 2023
  50. HASHIBE M, Wei M, Lee CJ, Tao R, et al
    Incident Cardiovascular Disease Risk Among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  51. KOTSOPOULOS J, Hathaway CA, Narod SA, Teras LR, et al
    Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1402-1410.
    PubMed     Abstract available


  52. KEHM RD, Lilge L, Walter EJ, White M, et al
    Socioeconomic Status at Birth and Breast Tissue Composition in Adolescence and Adulthood.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1294-1301.
    PubMed     Abstract available


    September 2023
  53. ERGAS IJ, Bradshaw PT, Cespedes Feliciano EM, Roh JM, et al
    Hypothetical interventions on diet quality and lifestyle factors to improve breast cancer survival: the Pathways Study.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


  54. MARIOTTO AB, Botta L, Bernasconi A, Zou Z, et al
    Prediction of risk of metastatic recurrence for female breast cancer patients in the presence of competing causes of death.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available


    August 2023
  55. KAUR M, Patterson A, Molina-Vega J, Rothschild H, et al
    Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1107-1113.
    PubMed     Abstract available


    July 2023
  56. KORIC A, Mark B, Chang CP, Lloyd S, et al
    Adverse Health Outcomes Among Rural And Urban Breast Cancer Survivors: A Population-Based Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jul 18:EPI-23-0421.
    PubMed     Abstract available


  57. HERBACH EL, Nash SH, Lizarraga IM, Carnahan RM, et al
    Patterns of evidence-based care for the diagnosis, staging, and first-line treatment of breast cancer by race-ethnicity: a SEER-Medicare study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jul 12:EPI-23-0218.
    PubMed     Abstract available


    June 2023
  58. CHOI J, Ha TW, Choi HM, Lee HB, et al
    Development of a breast cancer risk prediction model incorporating polygenic risk scores and non-genetic risk factors for Korean women.
    Cancer Epidemiol Biomarkers Prev. 2023 Jun 13:EPI-23-0064.
    PubMed     Abstract available


    April 2023
  59. TROESCHEL AN, Hartman TJ, McCullough LE, Ergas IJ, et al
    Associations of post-diagnosis lifestyle with prognosis in women with invasive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023 Apr 20:EPI-22-1274.
    PubMed     Abstract available


    March 2023
  60. MEYER DS, Millen AE, Nie J, Trevisan M, et al
    Dietary fats and all-cause and breast cancer specific mortality among women with breast cancer: The Western New York Exposures and Breast Cancer (WEB) Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 30:EPI-22-0881.
    PubMed     Abstract available


  61. LOU MW, Drummond AE, Swain CT, Milne RL, et al
    Linking physical activity to breast cancer via inflammation, Part 2: The effect of inflammation on breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 3:EPI-22-0929.
    PubMed     Abstract available


  62. SWAIN CT, Drummond AE, Milne RL, English DR, et al
    Linking physical activity to breast cancer risk via inflammation, Part 1: The effect of physical activity on inflammation.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 3:EPI-22-0928.
    PubMed     Abstract available


    February 2023
  63. MUSE ME, Carroll CD, Salas LA, Karagas MR, et al
    Application of novel breast biospecimen cell type adjustment identifies shared DNA methylation alterations in breast tissue and milk with breast cancer risk factors.
    Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-0405.
    PubMed     Abstract available


  64. JOHN EM, Koo J, Ingles SA, Kurian AW, et al
    Changes in breast cancer risk and risk factor profiles among U.S.-born and immigrant Asian American women residing in the San Francisco Bay Area.
    Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-1128.
    PubMed     Abstract available


  65. ROSENZWEIG MQ, Mazanec SR
    Racial Differences in Breast Cancer Therapeutic Toxicity: Implications for Practice.
    Cancer Epidemiol Biomarkers Prev. 2023;32:157-158.
    PubMed     Abstract available


  66. DE HAAN-DU J, Groenier KH, Wauben-Spaetgens B, Jalving M, et al
    The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care.
    Cancer Epidemiol Biomarkers Prev. 2023;32:252-259.
    PubMed     Abstract available


    January 2023
  67. SU YR, Buist DS, Lee JM, Ichikawa L, et al
    Performance of statistical and machine learning risk prediction models for surveillance benefits and failures in breast cancer survivors.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 25:EPI-22-0677.
    PubMed     Abstract available


  68. YASUI Y, Letsou W, Wang F, Im C, et al
    Inference on the Genetic Architecture of Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 18:EPI-22-1073.
    PubMed     Abstract available


  69. MAVADDAT N, Ficorella L, Carver T, Lee A, et al
    Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 13:EPI-22-0756.
    PubMed     Abstract available


    December 2022
  70. NARII N, Kito K, Sobue T, Zha L, et al
    Acrylamide and glycidamide hemoglobin adduct levels and breast cancer risk in Japanese women: A nested case-control study in the JPHC.
    Cancer Epidemiol Biomarkers Prev. 2022 Dec 16:EPI-22-0904.
    PubMed     Abstract available


  71. SWAIN CTV, Drummond AE, Milne RL, English DR, et al
    Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2106-2115.
    PubMed     Abstract available


  72. DRUMMOND AE, Swain CTV, Milne RL, English DR, et al
    Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2116-2125.
    PubMed     Abstract available


    November 2022

  73. Correction: Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2092.
    PubMed    


  74. DUCHESNEAU ED, Jackson BE, Webster-Clark M, Lund JL, et al
    The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2079-2086.
    PubMed     Abstract available


    October 2022
  75. MACCIOTTA A, Catalano A, Giraudo MT, Weiderpass E, et al
    Mediating role of lifestyle behaviours in the association between education and cancer: results from the European Prospective Investigation into Cancer and Nutrition.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 28. pii: 710109.
    PubMed     Abstract available


  76. HVIDTFELDT UA, Chen J, Rodopoulou S, Strak M, et al
    Breast cancer incidence in relation to long-term low-level exposure to air pollution in the ELAPSE pooled cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 10. pii: 709688.
    PubMed     Abstract available


  77. ASHI K, Ndom P, Gakwaya A, Makumbi T, et al
    Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 10. pii: 709687.
    PubMed     Abstract available


    September 2022
  78. HU X, Kaplan CM, Martin MY, Walker MS, et al
    Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor positive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 27. pii: 709495.
    PubMed     Abstract available


  79. WALENS A, Van Alsten SC, Olsson LT, Smith MA, et al
    RNA-based classification of homologous recombination deficiency in racially-diverse patients with breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 21. pii: 709340.
    PubMed     Abstract available


  80. CROSS T, George A, Attwood K, Zhang Y, et al
    Associations between Serum 25-hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Breast Cancer Patients: A Longitudinal Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 20. pii: 709294.
    PubMed     Abstract available


  81. YE H, Tang LY, Liang ZZ, Chen QX, et al
    Effects of infection-induced fever and the interaction with interleukin-6 rs1800796 polymorphism on the prognosis of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 9. pii: 709164.
    PubMed     Abstract available


  82. BAZAN JG, Obeng-Gyasi S
    Disparities in Early-Stage Breast Cancer and Survival-Letter.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1867.
    PubMed    


  83. PRIMM KM, Zhao H, Hernandez DC, Chang S, et al
    Disparities in Early-Stage Breast Cancer and Survival-Reply.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1868.
    PubMed    


    August 2022
  84. OLSSON LT, Walens A, Hamilton AM, Fleming JM, et al
    Obesity and Breast Cancer Metastasis Across Genomic Subtypes.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 16. pii: 707899.
    PubMed     Abstract available


  85. WANG T, Heng YJ, Baker GM, Bret-Mounet VC, et al
    Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses' Health Studies.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 1. pii: 707366.
    PubMed     Abstract available


    July 2022
  86. KORN AR, Reedy J, Brockton NT, Kahle LL, et al
    The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and cancer risk: a longitudinal analysis in the NIH-AARP Diet and Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 25. pii: 707213.
    PubMed     Abstract available


  87. WALLNER LP, Chen LH, Hogan TA, Brasfield FM, et al
    The influence of medical comorbidities on survival disparities in a multi-ethnic group of patients with de novo metastatic breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 21. pii: 707116.
    PubMed     Abstract available


  88. NORMANN AJ, Kang DW, Christopher CN, Norris MK, et al
    Improved Sleep Quality Is Associated with Reduced Insulin Resistance in Cancer Survivors Undertaking Circuit, Interval-Based Exercise.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1509-1510.
    PubMed     Abstract available


  89. BENASHLEY LW, Bucy AM, Wertheim BC, Blew R, et al
    Paclitaxel Treatment Effects on Neurofilament Light Chain (NF-L), a Possible Biomarker of Chemotherapy-Induced Peripheral Neuropathy (CIPN).
    Cancer Epidemiol Biomarkers Prev. 2022;31:1510-1511.
    PubMed     Abstract available


  90. BALLINGER TJ, Djuric Z, Sardesai S, Hovey K, et al
    Proton Pump Inhibitor Use and Obesity-Associated Cancers in the Women's Health Initiative.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1511.
    PubMed     Abstract available


  91. LECOMPTE CG, McDougall J, Walters ST, Toppmeyer D, et al
    Understanding Cancer Genetic Risk Assessment Intentions in a Tailored Risk Communication Intervention Randomized Controlled Trial.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1513-1514.
    PubMed     Abstract available


  92. BELLISSIMO MP, Canada JM, Jordan JH, Ladd AC, et al
    Changes in Physical Activity, Functional Capacity, and Cardiac Function during Breast Cancer Therapy.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1509.
    PubMed     Abstract available


  93. NYANTE SJ, Abraham L, Aiello Bowles EJ, Lee CI, et al
    Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1324-1333.
    PubMed     Abstract available


  94. BARNARD ME, Martheswaran T, Van Meter M, Buys SS, et al
    Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1313-1323.
    PubMed     Abstract available


  95. LESSER C, Mericq V, Reyes M, Garmendia ML, et al
    Habitual Phytoestrogen Intake Is Associated with Breast Composition in Girls at 2 Years after Menarche Onset.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1334-1340.
    PubMed     Abstract available


  96. PEILA R, Rohan TE
    Association of Prediagnostic Serum Levels of Vitamin D with Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1499-1502.
    PubMed     Abstract available


    June 2022
  97. AHEARN TU, Pal Choudhury P, Derkach A, Wiafe-Addai B, et al
    Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699329.
    PubMed     Abstract available


  98. ROSNER B, Glynn RJ, Eliassen AH, Hankinson SE, et al
    A multi-state survival model for time to breast cancer mortality among a cohort of initially disease-free women.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699326.
    PubMed     Abstract available


  99. ZAVALA VA, Casavilca-Zambrano S, Navarro Vasquez J, Castaneda CA, et al
    Association between ancestry-specific 6q25 variants and breast cancer subtypes in Peruvian women.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699327.
    PubMed     Abstract available


  100. BRADLEY CJ, Sabik LM, Entwistle J, Stevens JL, et al
    Role of Medicaid in Early Detection of Screening-Amenable Cancers.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1202-1208.
    PubMed     Abstract available


    May 2022
  101. MCWILLIAMS L, Groves S, Howell SJ, French DP, et al
    The impact of morbidity and disability on attendance at organised breast cancer screening programmes: A systematic review and meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2022 May 5. pii: 696307.
    PubMed     Abstract available


  102. MENDOZA JA, Miller CA, Martin KJ, Resnicow K, et al
    Examining the Association of Food Insecurity and Being Up-to-Date for Breast and Colorectal Cancer Screenings.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1017-1025.
    PubMed     Abstract available


    April 2022
  103. KOTSOPOULOS J, Lubinski J, Gronwald J, Menkiszak J, et al
    Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 27. pii: 694788.
    PubMed     Abstract available


  104. HAMILTON AM, Hurson AN, Olsson LT, Walens A, et al
    The landscape of immune microenvironments in racially-diverse breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 18. pii: 694482.
    PubMed     Abstract available


  105. WANG X, Cho-Phan CD, Hoskins KF, Calip GS, et al
    Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data.
    Cancer Epidemiol Biomarkers Prev. 2022;31:704-706.
    PubMed     Abstract available


    March 2022
  106. PRIMM KM, Zhao H, Hernandez DC, Chang S, et al
    A contemporary analysis of racial and ethnic disparities in diagnosis of early stage breast cancer and stage-specific survival by molecular subtype.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 21. pii: 682328.
    PubMed     Abstract available


  107. PALA V, Agnoli C, Cavalleri A, Rinaldi S, et al
    Pre-diagnostic levels of copper and zinc and breast cancer risk in the ORDET cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 4. pii: 682049.
    PubMed     Abstract available


  108. NGUYEN SM, Tran HT, Nguyen LM, Bui OT, et al
    Association of fruit, vegetable and animal food intakes with breast cancer risk overall and by molecular subtype among Vietnamese women.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 3. pii: 682000.
    PubMed     Abstract available


  109. MCDONALD JA, Vilfranc CL, Terry MB
    The Epidemiology of Pregnancy-Related Breast Cancers: Are We Ready to Deliver?
    Cancer Epidemiol Biomarkers Prev. 2022;31:518-520.
    PubMed     Abstract available


  110. HASLAM DE, John EM, Knight JA, Li Z, et al
    Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 1:EPI-22-1198.
    PubMed     Abstract available


    February 2022
  111. HOLDER EX, Houghton SC, Sanchez SS, Eliassen AH, et al
    Estrogenic activity and risk of invasive breast cancer among postmenopausal women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Feb 7. pii: 1055-9965.EPI-21-1157.
    PubMed     Abstract available


    January 2022
  112. MOORE J, Wang F, Pal T, Reid S, et al
    Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-0929.
    PubMed     Abstract available


  113. BRANTLEY KD, Zeleznik OA, Rosner B, Tamimi RM, et al
    Plasma Metabolomics and Breast Cancer Risk Over 20 Years of Follow-up Among Postmenopausal Women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-1023.
    PubMed     Abstract available


  114. STRANDBERG R, Czene K, Eriksson M, Hall P, et al
    Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 13. pii: 1055-9965.EPI-21-1011.
    PubMed     Abstract available


  115. NAIR RG, Lee SJC, Berry E, Argenbright KE, et al
    Long-term Mammography Adherence among Uninsured Women Enrolled in the Breast Screening and Patient Navigation (BSPAN) Program.
    Cancer Epidemiol Biomarkers Prev. 2022;31:77-84.
    PubMed     Abstract available


    December 2021
  116. PEILA R, Arthur RS, Dannenberg AJ, Rohan TE, et al
    Association of a healthy lifestyle index with risk of breast cancer among women with normal body mass index in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 21. pii: 1055-9965.EPI-21-0765.
    PubMed     Abstract available


  117. NIEHOFF NM, Terry MB, Bookwalter DB, Kaufman JD, et al
    Air pollution and breast cancer: an examination of modification by underlying familial breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 14. pii: 1055-9965.EPI-21-1140.
    PubMed     Abstract available


  118. CONNOR AE, Kaur M, Dibble KE, Visvanathan K, et al
    Racialized economic segregation and breast cancer mortality among women in Maryland.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 3. pii: 1055-9965.EPI-21-0923.
    PubMed     Abstract available


  119. TIN TIN S, Key TJ, Reeves GK
    Alcohol Intake and Endogenous Hormones in Pre- and Postmenopausal Women: Findings from the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2294-2301.
    PubMed     Abstract available


    November 2021
  120. VOHRA SN, Walens A, Hamilton AM, Sherman ME, et al
    Molecular and clinical characterization of postpartum-associated breast cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0940.
    PubMed     Abstract available


  121. NAZARIO CM, Rosario-Rosado RV, Schelske-Santos M, Mansilla-Rivera I, et al
    Sun exposure is associated with reduced breast cancer risk among women living in the Caribbean: The Atabey study in Puerto Rico.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0932.
    PubMed     Abstract available


  122. CHARVAT H, Freisling H, Noh H, Gaudet MM, et al
    Excess body fatness during early to mid-adulthood and survival from colorectal and breast cancer: a pooled analysis of five international cohort studies.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 15. pii: 1055-9965.EPI-21-0688.
    PubMed     Abstract available


  123. SIEGEL SD, Brooks MM, Sims-Mourtada J, Schug ZT, et al
    A Population Health Assessment in a Community Cancer Center Catchment Area: Triple negative breast cancer, alcohol use, and obesity in New Castle County, Delaware.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 4. pii: 1055-9965.EPI-21-1031.
    PubMed     Abstract available


  124. HURSON AN, Abubakar M, Hamilton AM, Conway K, et al
    TP53 pathway function, estrogen receptor status, and breast cancer risk factors in the Carolina Breast Cancer Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 4. pii: 1055-9965.EPI-21-0661.
    PubMed     Abstract available


  125. MARIOTTO AB, Zhang F, Buckman DW, Miller D, et al
    Characterizing Trends in Cancer Patients' Survival Using the JPSurv Software.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2001-2009.
    PubMed     Abstract available


    October 2021
  126. DONG W, Bensken WP, Kim U, Rose J, et al
    Phenotype Discovery and Geographic Disparities of Late-Stage Breast Cancer Diagnosis across U.S. Counties: A Machine Learning Approach.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0838.
    PubMed     Abstract available


  127. PENG C, Zeleznik OA, Shutta KH, Rosner BA, et al
    A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0837.
    PubMed     Abstract available


  128. ZHANG X, Wolff MS, Shen J, Parada H, et al
    Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0830.
    PubMed     Abstract available


  129. LYNCH BM, Milne RL, English DR, Brown KA, et al
    Linking physical activity to breast cancer: text mining results and a protocol for systematically reviewing three potential mechanistic pathways.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0435.
    PubMed     Abstract available


  130. DRUMMOND AE, Swain CTV, Brown KA, Dixon-Suen SC, et al
    Linking physical activity to breast cancer via sex steroid hormones Part 2: The effect of sex steroid hormones on breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0438.
    PubMed     Abstract available


  131. SWAIN CTV, Drummond AE, Boing L, Milne RL, et al
    Linking physical activity to breast cancer via sex hormones part 1: The effect of physical activity on sex steroid hormones.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0437.
    PubMed     Abstract available


    September 2021
  132. TAN VY, Bull CJ, Biernacka KM, Teumer A, et al
    Investigation of the interplay between circulating lipids and IGF-I and relevance to breast cancer risk: an observational and Mendelian randomization study.
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. pii: 1055-9965.EPI-21-0315.
    PubMed     Abstract available


  133. OMOFUMA OO, Peterson LL, Turner DP, Merchant AT, et al
    Dietary Advanced Glycation End-Products (AGEs) and Mortality After Breast Cancer in the Women's Health Initiative (WHI).
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. pii: 1055-9965.EPI-21-0610.
    PubMed     Abstract available


    August 2021
  134. BARON JA, Nichols HB, Anderson C, Safe S, et al
    Cigarette Smoking and Estrogen-Related Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021;30:1462-1471.
    PubMed     Abstract available


    June 2021
  135. PEILA R, Chlebowski R, Manson JE, Crane TE, et al
    Low-fat dietary modification and risk of ductal carcinoma in situ of the breast in the Women's Health Initiative Dietary Modification trial.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 29. pii: 1055-9965.EPI-21-0404.
    PubMed     Abstract available


    May 2021
  136. DIMOU N, Yarmolinsky J, Bouras E, Tsilidis KK, et al
    Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:953-964.
    PubMed     Abstract available


  137. WILSON LF, Tuesley KM, Webb PM, Dixon-Suen SC, et al
    Hysterectomy and Risk of Breast, Colorectal, Thyroid, and Kidney Cancer - an Australian Data Linkage Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:904-911.
    PubMed     Abstract available


    April 2021
  138. SHEPPARD VB, Sutton AL, Hurtado-de-Mendoza A, He J, et al
    Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:699-709.
    PubMed     Abstract available


    March 2021
  139. CARVER T, Hartley S, Lee A, Cunningham AP, et al
    CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.
    Cancer Epidemiol Biomarkers Prev. 2021;30:469-473.
    PubMed     Abstract available


    January 2021
  140. BENEFIELD HC, Zirpoli GR, Allott EH, Shan Y, et al
    Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium.
    Cancer Epidemiol Biomarkers Prev. 2021;30:71-79.
    PubMed     Abstract available


  141. SPRAGUE BL, Vacek PM, Mulrow SE, Evans MF, et al
    Collagen Organization in Relation to Ductal Carcinoma In Situ Pathology and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2021;30:80-88.
    PubMed     Abstract available


    August 2020
  142. GAGLIARDI A, Dugue PA, Nost TH, Southey MC, et al
    Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 11. pii: 1055-9965.EPI-20-0451.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.